NeoCore Technology Co., Ltd. (TPEX:4131)
Taiwan · Delayed Price · Currency is TWD 33.15
+0.10 (0.30%)
Jul 14, 2026, 12:04 PM CST
NeoCore Technology Market Cap
NeoCore Technology has a market cap or net worth of 1.32 billion as of July 14, 2026. Its market cap has decreased by -1.78% in one year.
Market Cap
1.32B
Enterprise Value
1.44B
Revenue
235.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.15
Market Cap Chart
Since November 3, 2004, NeoCore Technology's market cap has increased from 15.79M to 1.32B, an increase of 8,251.02%. That is a compound annual growth rate of 22.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.32B | -20.49% |
| Dec 31, 2025 | 1.66B | 31.25% |
| Dec 31, 2024 | 1.26B | 45.45% |
| Dec 29, 2023 | 869.00M | 123.11% |
| Dec 26, 2022 | 389.50M | 24.09% |
| Dec 28, 2021 | 313.90M | 1.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anti-Microbial Savior BioteQ | 1.66B |
| Advagene Biopharma | 1.48B |
| TaiRx | 1.45B |
| Andros Pharmaceuticals Co.,Ltd | 1.45B |
| GenMont Biotech Incorporation | 1.42B |
| Abnova (Taiwan) | 1.24B |
| Enimmune | 1.20B |
| BiOptic | 1.18B |